triple-negative-breast-cancer | Media Room | PressRelease.com

Tagged triple-negative-breast-cancer

Sci-Engi-Medco Solutions Inc. Announces PLOS Publication of a Novel Mechanism of Action for Its AAAPT Technology Expanding the Therapeutic Index of Difficult to Treat Cancers

Press Release Mar 5, 2021

Sci-Engi-Medco Solutions Inc. Announces PLOS Publication of a Novel Mechanism of Action for Its AAAPT Technology Expanding the Therapeutic Index of Difficult to Treat Cancers

-New Mechanism Targeting Multiple Pathways Allows Company's Proprietary Candidates to Work Synergistically with Current Therapeutics Read More

Press Release Jan 12, 2018

Sci-Engi-Medco Solutions Inc. Awarded SBIR Phase 1 NCI Contract to Study Its Lead Molecules in Preclinical Model of Triple Negative Breast Cancer

Read More

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

Press Release Dec 11, 2017

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

Read More

Press Release Apr 18, 2016

ImmunoBiochem Corporation Partners With the Centre for the Commercialization of Antibodies and Biologics at the University of Toronto to Advance New Antibody Drug Conjugates

Read More

First
Prev

1

Next
Last